These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6138036

  • 1. Comparative in vitro studies of Tiazofurin and a selenazole analog.
    Streeter DG, Robins RK.
    Biochem Biophys Res Commun; 1983 Sep 15; 115(2):544-50. PubMed ID: 6138036
    [Abstract] [Full Text] [Related]

  • 2. Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
    Jayaram HN, Ahluwalia GS, Dion RL, Gebeyehu G, Marquez VE, Kelley JA, Robins RK, Cooney DA, Johns DG.
    Biochem Pharmacol; 1983 Sep 01; 32(17):2633-6. PubMed ID: 6137224
    [No Abstract] [Full Text] [Related]

  • 3. Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
    Boritzki TJ, Berry DA, Besserer JA, Cook PD, Fry DW, Leopold WR, Jackson RC.
    Biochem Pharmacol; 1985 Apr 01; 34(7):1109-14. PubMed ID: 3985993
    [Abstract] [Full Text] [Related]

  • 4. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K, Sreenath A, Hao Z, Paull KD, Szekeres T, Cooney DA, Krohn K, Jayaram HN.
    Biochem Pharmacol; 1994 Oct 07; 48(7):1413-9. PubMed ID: 7945441
    [Abstract] [Full Text] [Related]

  • 5. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ, Pawlak K, Nguyen BT, Robins RK, Sadée W.
    Cancer Res; 1985 Nov 07; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [Abstract] [Full Text] [Related]

  • 6. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN, Ahluwalia GS, Jayaram HN, Cooney DA, Johns DG.
    J Clin Invest; 1985 Jan 07; 75(1):175-82. PubMed ID: 2856924
    [Abstract] [Full Text] [Related]

  • 7. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin.
    Ahluwalia GS, Jayaram HN, Plowman JP, Cooney DA, Johns DG.
    Biochem Pharmacol; 1984 Apr 15; 33(8):1195-203. PubMed ID: 6143562
    [Abstract] [Full Text] [Related]

  • 8. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).
    Jayaram HN, Dion RL, Glazer RI, Johns DG, Robins RK, Srivastava PC, Cooney DA.
    Biochem Pharmacol; 1982 Jul 15; 31(14):2371-80. PubMed ID: 6127085
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
    Berger NA, Berger SJ, Catino DM, Petzold SJ, Robins RK.
    J Clin Invest; 1985 Feb 15; 75(2):702-9. PubMed ID: 3919063
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD, O'Dwyer PJ, Trader MW.
    Cancer Res; 1986 Jul 15; 46(7):3396-400. PubMed ID: 3708573
    [Abstract] [Full Text] [Related]

  • 11. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
    Natsumeda Y, Yamada Y, Yamaji Y, Weber G.
    Biochem Biophys Res Commun; 1988 May 31; 153(1):321-7. PubMed ID: 2897852
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog.
    Pani A, Marongiu ME, Pinna E, Scintu F, Perra G, Montis AD, Manfredini S, La Colla P.
    Anticancer Res; 1998 May 31; 18(4A):2623-30. PubMed ID: 9703919
    [Abstract] [Full Text] [Related]

  • 13. Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.
    Gebeyehu G, Marquez VE, Van Cott A, Cooney DA, Kelley JA, Jayaram HN, Ahluwalia GS, Dion RL, Wilson YA, Johns DG.
    J Med Chem; 1985 Jan 31; 28(1):99-105. PubMed ID: 2856943
    [Abstract] [Full Text] [Related]

  • 14. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.
    Robins RK, Revankar GR, McKernan PA, Murray BK, Kirsi JJ, North JA.
    Adv Enzyme Regul; 1985 Jan 31; 24():29-43. PubMed ID: 2872781
    [Abstract] [Full Text] [Related]

  • 15. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G, Jayaram HN, Lapis E, Natsumeda Y, Yamada Y, Yamaji Y, Tricot GJ, Hoffman R.
    Adv Enzyme Regul; 1988 Jan 31; 27():405-33. PubMed ID: 2907968
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN, Pillwein K, Lui MS, Faderan MA, Weber G.
    Biochem Pharmacol; 1986 Feb 15; 35(4):587-93. PubMed ID: 2868729
    [Abstract] [Full Text] [Related]

  • 17. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
    Franchetti P, Cappellacci L, Grifantini M, Barzi A, Nocentini G, Yang H, O'Connor A, Jayaram HN, Carrell C, Goldstein BM.
    J Med Chem; 1995 Sep 15; 38(19):3829-37. PubMed ID: 7562914
    [Abstract] [Full Text] [Related]

  • 18. Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.
    Kirsi JJ, North JA, McKernan PA, Murray BK, Canonico PG, Huggins JW, Srivastava PC, Robins RK.
    Antimicrob Agents Chemother; 1983 Sep 15; 24(3):353-61. PubMed ID: 6615611
    [Abstract] [Full Text] [Related]

  • 19. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
    Cooney DA, Jayaram HN, Glazer RI, Kelley JA, Marquez VE, Gebeyehu G, Van Cott AC, Zwelling LA, Johns DG.
    Adv Enzyme Regul; 1983 Sep 15; 21():271-303. PubMed ID: 6152729
    [Abstract] [Full Text] [Related]

  • 20. Studies on the mechanism of action of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). VI. Biochemical and pharmacological studies on the degradation of thiazole-4-carboxamide adenine dinucleotide (TAD).
    Ahluwalia GS, Cooney DA, Marquez VE, Jayaram HN, Johns DG.
    Biochem Pharmacol; 1986 Nov 01; 35(21):3783-90. PubMed ID: 2877671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.